DrugPatentWatch

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Tradename: PROSCAR

Summary for Tradename: PROSCAR

Patents:2
Applicants:1
NDAs:1
Suppliers: see list1
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
drug
patent expirations by year for
 PROSCAR

Clinical Trials for: PROSCAR

A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy
Status: Recruiting Condition: Enlarged Prostate

An Observational Registry-Based Study of a Potential Link Between Finasteride (MK-0906) and Male Breast Cancer in 4 Nordic Countries (MK-0906-162/2003.021)
Status: Active, not recruiting Condition: Male Breast Cancer

Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
Status: Completed Condition: Healthy

Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions
Status: Completed Condition: Healthy

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions
Status: Completed Condition: Healthy

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
Status: Completed Condition: Healthy

Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
Status: Completed Condition: Retinal Disease

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition
Status: Completed Condition: Healthy

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition
Status: Completed Condition: Healthy

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
Status: Recruiting Condition: Prostate Cancer

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Exclusivity Expiration
Merck
PROSCAR
finasteride
TABLET; ORAL020180Jun 19, 1992RXYes5,886,184Y<disabled><disabled>
Merck
PROSCAR
finasteride
TABLET; ORAL020180Jun 19, 1992RXYes5,942,519<disabled><disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639

`abc